Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments by unknown
Isoforms of the Invariant Chain Regulate Transport of MHC 
Class II Molecules to Antigen Processing Compartments 
Petra A.M. Warmerdam, Eric O. Long, and Paul A. Roche* 
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, RockviUe, 
Maryland 20852; and *Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, 
Maryland 20892 
Abstract. Newly synthesized class II molecules of the 
major histocompatibility complex must be transported 
to endosomal compartments where antigens are pro- 
cessed for presentation to class II-restricted T cells. 
The invariant chain (Ii), which assembles with newly 
synthesized class II et- and [3-chains in the endoplasmic 
reticulum, carries one or more targeting signals for 
transport to endosomal compartments where Ii dissoci- 
ates from a[3Ii complexes. Here we show that the trans- 
port route of aBIi complexes is regulated selectively by 
two forms of Ii (p33 and p35) that are generated by the 
use of alternative translation initiation sites. Using a 
novel quantitative surface arrival assay based on label- 
ing with [6-3H]-D-galactose  combined with biochemical 
modification at the cell surface with neuraminidase, we 
demonstrate that newly synthesized tx[3Ii molecules 
containing the Ii-p33 isoform can be detected on the 
cell surface shortly after passage through the Golgi ap- 
paratus/trans-Golgj network. A substantial amount of 
these a[3Ii complexes are targeted to early endosomes 
either directly from the trans-Golgi  network or after in- 
ternalization from the cell surface before their delivery 
to antigen processing compartments. The fraction of 
otl3Ii complexes containing the p35 isoform of Ii with a 
longer cytosolic domain was not detected at the cell 
surface as determined by iodination of intact cells and 
the lack of susceptibility to neuraminidase trimming on 
ice. However, treatment with neuraminidase at 37°C 
did reveal that some of the et13Ii-p35 complexes tra- 
versed early endosomes. These results demonstrate 
that a fraction of newly synthesized class II molecules 
arrive at the cell surface as etl3Ii complexes before de- 
livery to antigen processing compartments and that 
class II al3Ii complexes associated with the two iso- 
forms of Ii are sorted to these compartments by differ- 
ent transport routes. 
I 
NTEGRAL membrane proteins can be targeted to en- 
docytic compartments following  either  one  of two 
known sorting pathways (Pearse and Robinson, 1990). 
AP-1  adaptors can recognize specific motifs in the cyto- 
plasmic domains of membrane proteins in the trans-Golgi 
network (TGN), leading to the association  of these pro- 
teins in clathrin-coated buds in the TGN and resulting in 
their direct transport to endosomal compartments. Alter- 
natively, the cytoplasmic domains of membrane proteins 
can  interact  with  plasma  membrane-associated  AP-2 
adaptors and this interaction can also result in transport to 
endosomal compartments, however, in this case, the mech- 
anism involves  internalization in clathrin-coated vesicles 
and fusion of these vesicles with early endosomes. Identifi- 
cation of the specific endosomal targeting pathway used 
by a particular protein can be difficult, since cytoplasmic 
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targeting signals  on proteins that are  targeted to endo- 
somes directly from the TGN can also be recognized at the 
plasma membrane and can lead to rapid internalization 
from the cell surface  (Harter and Mellman, 1992; Ogata 
and Fukuda, 1994). 
Major histocompatibility complex (MHC)  1 class II mol- 
ecules  are transmembrane glycoproteins that must reach 
endosomal compartments before they can exert their bio- 
logical function. These molecules bind antigenic peptides 
derived from internalized antigen and display them on the 
cell surface for recognition by specific CD4  ÷ T  lympho- 
cytes (Germain, 1994). However, class II molecules cannot 
bind  antigenic  peptides  until  a  "chaperone"  subunit, 
termed class II-associated invariant chain (Ii), has dissoci- 
ated from the al3Ii complex in compartments of the en- 
docytic pathway (Roche and Cresswell, 1990, 1991; New- 
comb  and  Cresswell,  1993a).  Ii  is  a  type  II  integral 
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associated  invariant  chain;  MHC,  major  histocompatibility  complex; 
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alternative splicing and by the use of two translation initia- 
tion sites that lead to the production of a  33-kD  major 
form of Ii (Ii-p33) as well as a 35-kD minor form (Ii-p35, 
representing ~10%  of all Ii; Strubin et al.,  1986). Unlike 
the p33  isoform of Ii, the p35  isoform contains a di-argi- 
nine motif that is responsible for the retention of Ii-p35 in 
the ER (Schutze et al., 1994). However, class II et[3Ii com- 
plexes containing Ii-p35 can leave the ER and transport 
through the Golgi apparatus and into antigen processing 
compartments, presumably due to the masking of the ER 
retention motif (Newcomb and Cresswell, 1993b). Two di- 
leucine-like motifs present in the cytoplasmic domain of 
all Ii isoforms mediate targeting of t~13Ii complexes to en- 
dosomes (Pieters et al., 1993; Bremnes et al., 1994; Odor- 
izzi  et  al.,  1994)  where  proteolytic enzymes degrade  Ii 
(Blum  and  Cresswell,  1988; Newcomb  and  Cresswell, 
1993b).  Finally, N2 h  after biosynthesis, mature et[~ het- 
erodimers begin to accumulate on the cell surface (Cress- 
well and Blum, 1988; Neefjes et al., 1990). 
Intracellular class  II molecules are  predominantly lo- 
cated in a late endosomal compartment termed the MHC 
class II compartment,,or MIIC; in human B-LCL (Peters 
et al.,  1991).  Since their 4nitial identification in B-LCL, 
similar compartments have been identified in macrophages 
(Harding  et  al.,  1990),  melanoma  cells  (Pieters  et  al., 
1991), and dendritic cells (Kleijmeer et al., 1995), whereas 
morphologically similar compartments with characteristics 
of earlier endosomes have been identified in mouse B cell 
lymphomas (Amigorena et al.,  1994).  MIIC are  distinct 
from conventional early or late endosomes and are thought 
to represent  a  specialization of the prelysosomal :system 
that has been adapted for efficient antigen processing and 
peptide loading onto newly synthesized class II molecules 
(Tulp et al., 1994; West et al., 1994; Rudensky et al., 1994; 
Qiu et al., 1994). Since most class II molecules in endocytic 
compartments localize to MIIC under steady-state condi- 
tions, it has been generally assumed that newly synthe- 
sized class II molecules are transported there directly from 
the TGN (Peters et al., 1991). However, it is also possible 
that transport to antigen processing compartments occurs 
via early endosomes, a pathway used by the mannose-6- 
phosphate receptor for delivery of certain lysosomal en- 
zymes to late endosomes and lysosomes (Ludwig et al., 
I991). Alternatively, newly synthesized class II molecules 
may be  targeted to  endosomal compartments following 
transport to the cell surface and rapid internalization. Sup- 
port  for this  hypothesis was  obtained in recent  studies 
showing that the amino terminal endosomal targeting sig- 
nal in the Ii cytoplasmic domain also functions as an effi- 
cient internalization signal, resulting in rapid endocytosis 
of class II a[3Ii complexes from the cell surface into endo- 
somal compartments in which :Ii dissociates from the com- 
plex  (Roche  et  al.,  1993).  Since  there  are  more  than 
500,000  mature  ctl3 heterodimers  per  B-LCL and  only 
~18,000  of these  are  associated with Ii at  any moment 
(Roche et al., 1993), the rapid passage of etl3Ii complexes 
through the cell surface can be  difficult to detect using 
standard biochemical assays. 
A  recent study with concanamycin B-treated cells, in 
which transport from early to late endosomes was inhib- 
ited,  concluded  that  the  majority of newly synthesized 
class II molecules were transported directly from the TGN 
to MIIC, even though a substantial amount of al3Ii com- 
plexes accumulated at the cell surface after treatment with 
this  drug  (Brnaroch  et  al.,  1995).  It  was  not  known 
whether these otl3Ii complexes arrived at the cell surface 
directly from the TGN or by escape from MIIC. Using a 
novel surface  arrival  assay, we  now provide  direct  evi- 
dence that class II et[3Ii complexes can be rapidly trans- 
ported from the TGN to the cell surface. A  substantial 
amount of newly synthesized al3Ii complexes containing 
Ii-p33 are targeted directly to the cell surface/early endo- 
some before entering more acidic antigen processing com- 
partments. By contrast, al3Ii complexes containing Ii-p35 
are not found to travel via the cell surface, but appear to 
be targeted directly to early/late endosomes before their 
delivery to antigen processing compartments. 
Materials and Methods 
Cell Lines and Antibodies 
The Epstein-Barr virus-transformed human B  lymphoblastoid cell lines 
(B-LCL) 721.45 (Kavathas et al., 1980) and JY (Peters et aL, 1991)  were 
cultured in RPMI  1640 supplemented with 10%  bovine serum and 5% 
FCS. Most experiments have been carried out using both B-LCL 721.45 
and B-LCL JY and the results obtained were always similar. The figure 
legend indicates which cell line was used in the experiment shown. MHC 
class I molecules were isolated with mAb w6/32 (Amer. Type Culture Col- 
lection, Rockville, MD). MHC class II molecules were isolated using rab- 
bit anti-DR 13-chain serum:(Karp et al., 1990)  or mAb DA6.147 (Guy et 
al., 1982) as indicated. Total li was isolated with the mAb PIN.I.1 (Roche 
et al., 1991).  Ii-p35 was isolated with affinity-purified rabbit anti-p35 anti- 
serum RIp35N (Roche et al., 1991; provided by Dr. Peter Cresswell, Yale 
University School of Medicine) or an affinity-purified antiserum gener- 
ated against the p35 amino terminal sequence MHRRRSRS (2-amino- 
caprylic acid)2 using conventional techniques. 
Metabolic Labeling ofB-LCL 
B-LCLwere radiolabeled biosynthetically with [35S]methionine or surface 
iodinated with [125I] as described previously (Machamer and CressweU, 
1982; Roche et al., 1993). Before labeling with [6-3H]-D-galactose ([3H]ga- 
lactose), B-LCL were cultured at 37°C in RPMI 1640 medium containing 
10 mM Hepes (pH 7.4), 3% dialyzed FCS, and 0.1 mM o-mannose for 1-3 
h to "starve" the cells of galactose. D-Mannose was added to eliminate the 
possibility  that  contaminants of  [3H]-o-mannose  in  the  [3H]galactose 
preparation  or biosynthetic conversion of [3H]gaiactose to  [3H]-D-man- 
nose could label cellular glycoproteins. The cells (40 ×  1/Y'/ml) were then 
labeled at 37°C with 1 mCi [3H]galactose (20-50 Ci/mmol; DuPont New 
England Nuclear, Boston, MA or ICN Radioehemicals, Costa Mesa, CA) 
in RPMI containing 0.1 mM n-mannose, and 3% dialyzed FCS. In experi- 
ments in which neuraminidase (NANAse) was incubated at 37°C shortly 
after pulse labeling, the labeling medium consisted of RPMI 1640 supple- 
mented with 0.1 mM D-mannose, 1 mM MgCI  2, 1 mM CaClz, and 1 mg/ml 
bovine serum albumin (BSA). The labeling time is specified for each ex- 
periment. The chase was started by adding an excess of unlabeled o-galac- 
rose (0.2 mg/ml) to the culture. In the case of long chase times, the cells 
were pelleted directly after labeling and unused free radiolabel  was re- 
moved. The cells were  then chased in regular culture medium supple- 
mented with 0.1 mM o-mannose and 0.02 mg/ml o-galactose. 
Desialylation with Neuraminidase 
Radiolabeled B-LCL (5-10 ×  106 cells/ml) were incubated alone or with 
0.1 U/ml Vibrio  cholerae NANAse (Calbiochem-Novabiochem Corp., La 
Jolla, CA) in RPMI containing 1 mM CaC12, 1 mM MgCI  2 and 0.1 mg/ml 
BSA either on ice for 2 h or for various times at 37°C as indicated. NANAse 
activity on the cells was completely inhibited by adding the highly glycosy- 
lated NANAse substrate fetuin (containing small amounts of N-acetyl- 
neuraminic acid; GIBCO/BRL, Gaithersburg, MD). The desialylated cells 
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Solution containing 0.5 mg/ml fetuin. 
lmmunoprecipitations 
B-LCL (20--40 × 106/ml) were lysed on ice for 1 h in 1% Triton X-100,10 
mM Tris-HCL 150 mM NaCI, pH 7.4 containing 1 mg/ml BSA, 0.5 mgfml 
fetuin,  5 mM iodoacetamide,  0.1  mM N-p-tosyl-L,lysylchloromethyl  ke- 
tone, 0.5 mM PMSF and 10 mM EDTA. Nuclei and cellular debris were 
removed by centrifngation.  The lysates were precleared with rabbit anti  L 
mouse immunoglobuiin serum and protein A-agarose (Sigma Chem, Co., 
St. Louis, MO) or with  an irrelevant isotype-tnatehed  mouse antibody 
(MOPC21;  Sigma  Chem.  Co.)  and rabbit anti-mouse immunoglobulin 
coated protein A-agarose. Lysates were then incubated  for at least 2 h 
with specific antibodies  at 4°C. Subsequently,  the lysates were incubated 
with  protein  A-agarose  or  with  rabbit  anti-mouse  immunoglobulin 
coated protein A-agarose for an additional hour at 4°C. The immunopre- 
cipitates were washed three times with 10 mM Tris, 150 mM NaC1, pH 7.4 
containing 0.1% Triton X-100 and once with 10 mM Tris, pH 7.4. The im- 
munoprecipitates were analyzed  on two-dimensional  get analysis (non- 
equilibrium  pH  gradient  electrophoresis followed  by  reducing  SDS- 
PAGE; Machamer and Cresswell,  1982) or quantitatively  analyzed  for 
their terminal carbohydrate content in the 13-gaiactosidase  assay. 
[3-Galactosidase  Assay 
B-LCL were metabolically  labeled  with [3H]galactose and identical  ali- 
quots were either incubated  with NANAse or incubated in buffer alone 
before the isolation of either class I or class II molecules by immunopre- 
cipitation.  The immunoprecipitates  were digested with 5 mg/ml pronase 
(Calbiochem) in 50 mM sodium acetate, pH 6.0, for 18 h at 37~C. The sam- 
ples were then heated to 100°C for 10 min to inactivate the pronase, and 
passed through a Sephadex G-15 column equilibrated  with 50 mM sodium 
acetate~ 0.1 mg/ml BSA, pH 6. The two fractions containing the majority 
of the [3H]galactose labeled glycopeptides were pooled and digested with 
5 mU of Diplococcus pneumoniae 13-galactosidase  (Boehringer Mannheim 
Corp.,  Indianapolis,  IN) for 18 h at 37°C. The 13-galactosidase digested 
samples were passed through a Sephadex G-15 column  equilibrated  in 
PBS/0.1 mg/ml BSA in order to separate the noncleaved  [3H]galactose 
containing  glycopeptide  (peak  1)  from the cleaved, free [SH]galactose 
(peak 2). Fractions  were collected  and counted in a liquid  scintillation 
counter. 
To specifically determine the effect of NANAse on the release of ter- 
minal gatactose by 13-galactosidase,  the amount of free ['3H]galactose re- 
leased from non-NANAse-treated  samples (expressed as a fraction of the 
total clam) was subtracted from the amount of free [3H]galactose released 
from the NANAse-treated samples (also expressed as a fraction of the to- 
tal cpm~ tO arrive at a percentage of free [3H]galactose released as a con- 
sequence of NANAse treatment. Since different  glycoproteins possess dif- 
ferent amounts of sialic acid residues  and 13-1,4 galactose  linkages  and 
therefore serve more or less well as 13-galactosidase  substrates,  the maxi- 
mum amount of cleavable galactose was determined by adding 0.1 U/ml 
NANAse to the cell lysis buffer before immunoprecipitation  and analysis 
in the [3-galactosidase  assay. All data were normalized using this value and 
are expressed as a fraction of the maximum amount cleavable and plotted 
as "relative percent terminal galactose." 
Results 
Comparison of  MHC Class H Molecules Labeled with 
[35SlMethionine or [3H]Galactose 
To determine the kinetics of MHC class II molecule trans- 
port to the cell surface, we attempted to identify a biosyn- 
thetic pulse-chase labeling protocol that would not be af- 
fected by ER retention of free Ii. Conventional metabolic 
labeling for 4 h with [35S]methionine and immunoprecipi- 
tation with anti-class II mAb revealed the presence of both 
ER-retained,  high mannose  class  II  c~-, [3-, and  Ii  chains 
(noted by arrowheads) as well as post-ER, complex carbo- 
hydrate forms of class II c~-, [3-, and Ii chains (Fig. 1, upper 
panel).  In addition, the large pool of free, ER-retained Ii 
assembles slowly with nonradioactive  class II ot- and [3-chains 
synthesized during a subsequent chase and only then ac- 
quires a complex carbohydrate (mature) phenotype. ~e 
net result of this process is that transport of radioiabeled 
class II molecules from the ER does not appear synchro- 
nous using this labeling protocol. 
To circumvent these difficulties,  we chose to label cells 
with  [3H]galactose.  As the enzyme [3-1,4-gaiactosyltrans- 
ferase resides in the trans-cisternae  of the Golgi apparatus 
(Roth and Berger, 1982), glycoproteins will only be tagged 
with this radiolabel once they have reached this compart- 
ment. Therefore, all three subunits of the multimeric a[3Ii 
complex are labeled simultaneously, and the large excess 
of ER-retained Ii will not interfere with pulse/chase analy- 
ses. Immunoprecipitation of [3H]galactose-labeled class Ii 
molecules revealed only mature forms of or, [3, and Ii con- 
taining complex carbohydrates (Fig. 1, lower  panel), elimi- 
nating the possibility that  [3H]galactose  was biosyntheti- 
cally converted to another carbohydrate that could label 
immature class II molecules in the ER, In addition to the 
predominant p33 form of Ii, the more basic p35 form of Ii 
is also labeled using this procedure, indicating that al3Ii 
complexes containing  a  p35  form of Ii reach  galactosyl- 
transferase-containing  compartments.  Immunopr~cipitates 
obtained using anti-DR  and  anti-Ii  antisera  were essen- 
tially identical, showing that free at3 heterodimers or free 
Ii are not labeled by this procedure (data not shown). 
Cell surface arrival  of giycoproteins can be determined 
by the susceptibility of their sialic acid residues to NANAse 
digestion on ice (Neefjes et al., 1990). To characterize the 
two-dimensional PAGE pattern of desialylated class iI a-, 
[3-,  and  Ii-chains,  [3H]galactose-labeled  B-LCL  lysates 
were incubated alone (Fig. 2 A) or with NANAse (Fig. 2 
B) before isolation of class II molecules. NANAse treat- 
ment of the B-LCL lysate resulted in a dramatic basic shift 
Figure  1.  Comparison  of  [35S]methionine-  and  [3H]galactose- 
labeled HLA-DR by two-dimensional  PAGE. B-LCL were radio- 
labeled with [35S]methionine for 4 h or with [3Hlgalactose for 30 
min. After radiolabeling, the cells were washed, lysed, and class 
II molecules were precipitated using the anti-DR mAb DA6.14Z 
The  immunoprecipitates were analyzed by nonequilibriurn pH 
gradient electrophoresis from right to left (acidic to basic) fol- 
lowed by reducing SDS-PAGE. The positions of the DR a- and 
[3-chains as well as the class II associated Ii-p33 and Ii-p35 iso- 
forms are indicated. The migration of the nonsialylated forms of 
the a-, 13-, and Ii chains is indicated by arrowheads. 
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by two-dimensional PAGE and the quantitative  13-galactosidase 
assay. B-LCL 721.45 were radiolabeled with [3H]galactose for 30 
rain, divided into two equivalent samples and washed in ice cold 
RPMI. The ceils were lysed for 1 h in lysis buffer alone (A and C) 
or in lysis buffer containing 0.1 U/ml NANAse (B and D). MHC 
class II molecules were isolated using an anti-DR 13-chain serum. 
After immunoprecipitation,  87% of the samples were analyzed 
by two dimensional  PAGE (A  and  B) and  13%  was used  for 
quantitative  analysis to determine the amount of terminal galac- 
tose residues present on each sample (C and D). 
of the class II 13-chain and Ii spots. (The use of NEPHGE 
in  the  first  dimension  does  not  allow  resolution  of the 
acidic DR a-chain spots.) This experiment also confirms 
that  the spots  observed in  the  untreated samples  corre- 
sponded to sialylated forms of the DR 13-chain and Ii and 
demonstrates  that  labeling  of  immature,  ER-localized 
class II molecules did not occur. (The relative position of 
each spot was determined by alignment with a partially de- 
sialylated sample.) An identical pattern was observed after 
extensive incubation with NANAse  or when  125I-labeled 
0t[3Ii complexes were boiled  before NANAse  treatment 
(data  not shown).  As  noted previously, NANAse  treat- 
ment does not cause all class II [3-chain or Ii spots to mi- 
grate  at  a  single,  distinct position, suggesting  that  other 
charge modifications not susceptible  to NANAse  diges- 
tion account for this heterogeneity (Machamer and Cress- 
well, 1984). 
A Quantitative Assay  for the Arrival of  MHC Class H 
Molecules at the Cell Surface 
In  addition  to visualizing  sialylated vs desialylated oL[3Ii 
complexes using an electrophoretic assay, we also adapted 
an assay to quantitate the extent of desialylation of o~13Ii 
complexes using the enzyme [3-galactosidase (Duncan and 
Kornfeld,  1988).  The  assay  is  based  upon  the  exquisite 
specificity  of  [3-galactosidase  for  the  cleavage  of  [~-1,4 
linked  terminal  galactose residues  on complex carbohy- 
drates. In most N-linked complex oligosaccharides, galac- 
tose is not the terminal carbohydrate residue, but is gener- 
ally extended by one or more sialic acid residues (Kornfeld 
and  Kornfeld,  1985).  Since  NANAse  can  remove these 
sialic acid residues, NANAse treatment of most complex 
carbohydrates leads to the exposure of terminal galactose 
residues that become substrates  for 13-galactosidase.  As  a 
result, incubation of NANAse-treated glycoprotein prepa- 
rations  with  13-galactosidase  allows  quantitation  of  the 
amount of terminal galactose residues exposed and there- 
fore acts as a quantifiable indicator for the extent of desial- 
ylation of surface exposed glycoproteins. 
Equivalent aliquots of the immunoprecipitates shown in 
Fig. 2, A and B were analyzed in the 13-galactosidase  assay. 
Gel filtration chromatography of ~-galactosidase-treated 
samples  demonstrated  that  the  high  molecular  weight 
[3H]galactose containing glycopeptide (Fig.  2,  C  and  D; 
peak 1) could be easily separated from free [3H]galactose 
(Fig. 2, C and D; peak 2) in this assay. For non-NANAse 
treated  3H-labeled  otl3Ii complexes,  ~12%  of  the  total 
amount of cpm could be released by [3-galactosidase (Fig. 
2  C),  representing  the  percentage of terminal  galactose 
residues present in the labeled pool of molecules. By con- 
trast,  NANAse  digestion  of identical samples  that  were 
completely  denatured  before  (3-galactosidase  treatment 
resulted in the release of 69% of the total cpm (Fig. 2 D). 
It should be emphasized that results from independent ex- 
periments were remarkably reproducible. Less than quan- 
titative release of [3H]galactose is presumably due to the 
restricted specificity of the NANAse  and 13-galactosidase 
preparations for the cleavage of particular carbohydrate 
linkages as well as to the existence of galactose residues 
that receive additional complex carbohydrates not cleav- 
able by NANAse (Fukuda, 1991). 
To test the validity of the quantitative NANAse/13-galac- 
tosidase assay in analyzing the rate of cell surface arrival of 
MHC glycoproteins, B-LCL were labeled with [3H]galac- 
tose and chased for various times to allow processing and 
transport of MHC molecules. The cells were then either 
untreated or treated with NANAse on ice and the surface 
arrival of MHC class I and class II molecules determined 
using the quantitative NANAse/~-galactosidase assay.  The 
data clearly show that MHC class I molecules were rapidly 
transported to the cell surface (tl/2 =  15-20 min) from the 
TGN (Fig. 3, filled symbols). By contrast, it took ~2 h of 
chase for the first detectable MHC class II molecules to 
accumulate at the cell surface and 3.5 h for half of the class 
II molecules to reach the cell surface (Fig. 3, open sym- 
bols). These data are in excellent agreement with previ- 
ously  published  reports  (Cresswell  and  Blum,  1988; 
Neefjes et al.,  1990) and demonstrate that biosynthetic la- 
beling  with  [3H]galactose combined  with  the  NANAse/ 
[3-galactosidase assay is able to accurately quantitate and 
distinguish cell surface arrival rates of different glycopro- 
teins. 
aflIi Complexes  Can Arrive at the Cell Surface Rapidly 
after Exit  from the TGN 
We have previously shown that class II et[3Ii complexes are 
very rapidly internalized from the plasma  membrane of 
B-LCL (Roche et  al.,  1993).  While  the experiments de- 
scribed above confirm that newly synthesized class II mol- 
ecules accumulate on the plasma membrane slowly, they 
do not allow accurate identification of small populations 
of class II molecules that might appear rapidly but only 
transiently on the cell surface before internalization into 
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Figure 3.  Kinetics  of cell  surface  arrival  of MHC  class  I  and 
MHC class II molecules. B-LCL 721.45 were radiolabeled with 
[3H]galactose  for 30 min, and chased for various times at 37°C. At 
each time point, cells were digested with NANAse on ice. After 2 h 
incubation with NANAse, 0.5 mg/ml fetuin was added, the cells 
were washed twice in RPMI/fetuin, and subsequently lysed in the 
presence of fetuin. Class II molecules were isolated using mAb 
DA6.147 (open symbols),  whereas class I molecules were isolated 
using mAb w6/32  (filled symbols). After immunoprecipitation, 
samples were analyzed using the quantitative 13-galactosidase as- 
say, and the relative percent terminal galactose was calculated as 
described in the text. 
endosomes.  To identify  the  rate  at  which newly synthe- 
sized ett3Ii complexes reach the cell surface from the Golgi 
apparatus,  B-LCL were  pulse-labeled  with  [3H]galactose 
for 15 min,  chased for various times,  and incubated  with 
NANAse on ice before cell lysis and the isolation of class 
II ot~Ii  complexes  (Fig.  4).  After  as  little  as  10  min  of 
chase, extracellular NANAse was capable of desialylating 
small amounts of [3H]galactose-labeled otl3Ii complexes, as 
evidenced by the appearance of new Ii spots migrating at a 
more  basic  position  only following  NANAse  treatment. 
Desialylation  was more readily observed after 20 min of 
chase. Note that despite the addition  of excess unlabeled 
galactose,  labeling  with  [3H]galactose  continued  during 
the first 20 min of chase. Quantitation using the NANAse/ 
[3-galactosidase assay revealed that 5% of the total pool of 
labeled ct[3Ii complexes was present on the cell surface af- 
ter  20 min of chase  (not  shown).  It is  important  to note 
that desialylation of etlMi was not observed without chase, 
confirming  that  the  effect  of  NANAse  was  dependent 
upon transport of etl3Ii out of the  Golgi apparatus/TGN. 
These  data demonstrate  that  a  fraction of newly synthe- 
sized et[3Ii complexes can arrive rapidly at the cell surface 
from the Golgi apparatus. 
A Substantial amount of aflli Complexes Reach the 
Cell SurfacelEarly Endosomes before Entry in Antigen 
Processing Compartments 
Since  surface  e~3Ii  complexes  are  rapidly  internalized,  a 
large fraction of etl3Ii complexes would not be expected to 
be present at the cell surface at any given time.  In an at- 
tempt to capture more of the class II molecules that tran- 
siently  pass  through  the  cell  surface  en  route  to  antigen 
processing compartments, B-LCL were pulse labeled with 
[3H]galactose and chased for various times before a 5-min 
treatment of the cells with NANAse at 37°C or with NANAse 
on ice. Since this experimental design includes a 37°C incu- 
bation in the presence of NANAse, we cannot exclude the 
possibility  of  NANAse  internalization  and  trimming  of 
class II molecules in early endosomes. The short NANAse 
treatment  does, however, rule  out cleavage of sialic  acid 
residues in later endocytic compartments. 
The  results  of the  NANAse/13-galactosidase  assay  for 
this experiment are shown in Fig. 5. As anticipated, MHC 
class I molecules were accessible to NANAse on ice after 
even brief times  of chase,  demonstrating  rapid  arrival  at 
the cell surface (Fig. 5 A, open symbols). Incubation with 
Figure 4.  Rapid transport of [SH]galactose-labeled MHC class II molecules to the cell surface. B-LCL 721.45  were radiolabeled with 
[3H]galactose  for 15 min and chased for up to 20 rain at 37°C. Samples chased 0 min (0'), 10 rain (10'), and 20 min (20')  were washed in 
ice cold RPMI and incubated in the absence (control)  or presence (+NANAse) of NANAse for 2 h on ice. The cells were then washed 
extensively in RPMI medium containing 0.5 mg/ml fetuin, lysed, and MHC class II molecules isolated and analyzed by two-dimensional 
PAGE. Arrowheads indicate the mobility of the desialylated subunits. (The species migrating just below the desialylated Ii subunits 
most likely represent galactosylated but not yet sialylated Ii molecules and are therefore refractory to NANAse trimming.) 
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Figure 5.  Newly synthesized molecules intersect  with NANAse 
on the cell surface and/or early endosomes. B-LCL 721.45 were 
radiolabeled for 15 min with [3H]galactose and chased by adding 
0.2 mg/ml unlabeled o-galactose to the samples for 0, 15, 30, or 45 
min. After each chase point ceils were split three ways; one sam- 
ple served as a negative control; a second sample was digested 
with NANAse for 2 h on ice (open symbols); a third sample was 
digested with NANAse for 5 min at 37°C (filled symbols).•  MHC 
class I (A) and MHC class II molecules (B) were precipitated  us- 
ing mAb w6/32 and mAb DA6.147, respectively. The immuno- 
precipitates were analyzed in the 13-galactosidase assay, and the 
relative percent terminal galactose was calculated as described in 
the text. 
NANAse for 5 min at 37°C did not result in complete de- 
sialylation of class I molecules, however, but it did result in 
desialylation to ,~75 % of the maximum obtained by incu- 
bation with NANAse on ice (Fig. 5 A,filled symbols). 
Class 11 molecules were isolated and analyzed in parallel 
experiments. At all chase points 3-5%  of newly synthe- 
sized class II molecules were accessible to NANAse on ice 
(Fig. 5 B, open symbols).  Interestingly, treatment of the 
cells with NANAse for only 5 min at 37°C revealed a flux 
of  desialylated  class  11  molecules  which  exceeded  the 
amount cleavable on ice, reaching a peak of 14% after 15 
min of chase despite the fact that desialylation for 5 min at 
37°C is not completely efficient (Fig. 5 B, filled symbols). 
The increase in desialylation observed following NANAse 
digestion at 37°C as opposed to NANAse digestion on ice 
continued for up to i h of chase. These results suggest that 
a  substantial fraction of newly synthesized MHC class II 
molecules intersect with NANAse shortly after leaving the 
TGN and are targeted to the cell surface and/or early en- 
dosomes before their delivery to later, more acidic antigen 
processing compartments. 
a~Ii Complexes Containing p33 or i)35 Isoforms Are 
Targeted Differentially into Endosomal Compartments 
Very long exposures of the two-dimensional gels shown in 
Fig. 4 revealed that whereas the p33 form of class II-asso- 
ciated Ii was sensitive to NANAse  digestion on ice, the 
p35 form of class II-associated Ii was not, suggesting that 
class II molecules containing the p35 form of Ii were not 
present  at  the  cell surface. To test this directly, B-LCL 
were radiolabeled with 125I on ice and surface ctl3Ii com- 
plexes were isolated using an isoform-independent anti-Ii 
antibody.  Immunoprecipitation  with  this  antibody  re- 
vealed the existence of surface al3Ii complexes containing 
sialylated Ii-p33  but  did  not reveal any otl3Ii complexes 
containing Ii-p35. (It should be noted that the class II or- 
and  13-chains do not label well with  this labeling proce- 
dure; Roche et al., 1992.) To exclude the possibility that 
the p35 isoform of li is not accessible for iodination (even 
though the extracellular domain of Ii-p35  is identical to 
the extracellular domain of Ii-p33), we isolated otl3Ii com- 
plexes using an 1i-p35-specific antiserum. Previous studies 
have demonstrated that class 11 ctlMi complexes exist as 
nonamers which can contain both Ii-p33  and  Ii-p35  iso- 
forms (Roche et al., 1991). For this reason, even if the Ii- 
p35 isoform present in cell surface txl~Ii complexes could 
not be labeled with 1251, other iodinated components of the 
nonameric ctl3Ii complex should be labeled and would be 
detected. However, Fig. 6 (,4) demonstrates that no iodi- 
nated components of class II otl3Ii complexes could be de- 
tected after immunoprecipitation with the anti-Ii-p35 anti- 
serum.  This  was  not  due  to  a  nonfunctional  antibody 
because this antiserum effectively precipitated [3H]galac- 
tose-labeled al3Ii complexes (Fig. 6 B). Note that these 
complexes also contain the li-p33 isoform (due to the pres- 
ence of mixed Ii trimers in the ot131i  nonamer). In addition, 
intracellular Ii-p35 could be clearly labeled by iodination 
of nonviable, permeabilized cells (data not shown). These 
data, together with NANAse  digestion of [3H]galactose- 
labeled  txl3Ii complexes, indicate  that  Ii-p35  containing 
oLI3Ii complexes are not present at the cell surface. 
The specific labeling of li-p35 containing class II al3Ii 
complexes in the Golgi apparatus/TGN with [3H]galactose 
and the identification of sialic acid residues on these com- 
plexes, together with our failure to detect Ii-p35 contain- 
ing class  11 ctlMi complexes on the  cell surface, demon- 
strates  that  these  complexes  are  present  in  the  Golgi 
apparatus and suggests that they are either retained there 
or that they are transported  to endocytic compartments 
using a pathway distinct from that used by Ii-p33 contain- 
ing od31i complexes. To determine whether Ii-p35 contain- 
ing class II otlMi complexes were transported to endosomal 
compartments,  B-LCL pulse-labeled  with  [3H]galactose 
were chased for various times in the absence or presence 
of the endosomal protease inhibitor leupeptin. The major- 
ity of both Ii-p33 and p35 isoforms were degraded and dis- 
sociated from class  II ctl3Ii complexes within 90 min  of 
chase in the absence of leupeptin (Fig. 7, left panels). By 
contrast, the dissociation of both Ii-p33 and p35 isoforms 
from ctl3Ii complexes was significantly inhibited by inclu- 
sion of leupeptin in the chase medium, and both remain 
clearly associated with class II tx- and 13-chains even after 
180 min of chase (Fig. 7, right panels). These results dem- 
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B-LCL were pulse-labeled with [3H]galactose for 15 min 
and Ii-p35 containing a~3Ii complexes present at the cell 
surface at various times were isolated and analyzed using 
the  NANAse/[3-galactosidase  assay.  In  parallel  experi- 
ments, the incubation was allowed to continue for 5 min in 
the presence of NANAse  at 37°C  before 13-galactosidase 
treatment  and  quantitative  analysis  of [3H]galactose re- 
lease. The time course of NANAse  sensitivity of Ii-p35 
ctl3Ii complexes on ice vs 37°C is shown in Fig. 8. Unlike 
the results obtained with the entire pool of otl3Ii complexes 
(Fig. 5), virtually no alMi complexes containing Ii-p35 mol- 
ecules could be desialylated when the cells were incubated 
with NANAse  on ice  (open symbols).  These results  are 
consistent with our inability to detect Ii-p35 on the plasma 
membrane as shown in Fig. 6. Incubation with NANAse 
during the last 5 min of chase (filled symbols) showed that 
some Ii-p35 containing etl3Ii complexes could be desialy- 
lated. Since desialylation was not detectable by NANAse 
treatment on ice, this result suggests that NANAse had in- 
ternalized under these conditions and had cleaved Ii-p35 
in early endocytic compartments. It should be emphasized 
that in this study the percentage of et13Ii-p35 on the cell 
surface is expressed relative to the total amount of et13Ii- 
p35 present in the sample and not to the total amount of 
all  otl3Ii complexes  synthesized  in  the  cells:  Taken  to- 
gether, the lack of NANAse cleavage on ice and the lack 
of surface iodination of Ii-p35 containing etl3Ii complexes 
show that Ii-p33 and Ii-p35 containing et[3Ii complexes are 
targeted differently from the TGN to endosomal compart- 
ments. 
Figure 6.  ctlMi-p35 complexes are not detectable at the cell sur- 
face. (A) B-LCL 721.45 were iodinated on ice, washed, and etl3Ii 
complexes were isolated  from the  lysates  using mAb  PIN.I.1 
(recognizing  all isoforms  of Ii) or a  rabbit anti-p35  antiserum 
(recognizing the p35 form of Ii only). The precipitates were ana- 
lyzed using two-dimensional PAGE. (B) B-LCL 721.45 were ra- 
diolabeled  with [3H]galactose for 1 h and al3Ii complexes were 
isolated from lysates using the anti-DR mAb DA6.147 (recogniz- 
ing class II molecules associated with all isoforms of Ii) or a rab- 
bit anti-p35 antiserum (recognizing class II molecules specifically 
associated with the p35 form of Ii). 
onstrate that the etlMi complexes labeled in the TGN with 
[3H]galactose are  targeted into the  endosomal compart- 
ments and are not retained in or retrieved from the Golgi 
apparatus/TGN. These results are also in agreement with 
previous reports showing that leupeptin-induced peptides 
derived from Ii-p35  can  be  generated  in  B-LCL (New- 
comb and Cresswell, 1993b). 
To confirm that Ii-p35 containing etlMi complexes arrive 
Discussion 
We have demonstrated that  the isoform of Ii associated 
with class II ot~3-dimers regulates the transport route taken 
by class II al3Ii complexes to antigen processing compart- 
ments. This was made possible by the use of an assay de- 
signed to quantitate cell surface arrival of newly synthe- 
sized  MHC glycoproteins.  The  sensitivity  of  the  assay 
made it possible to detect a transient population of MHC 
class  II  molecules on  the  surface of B-LCL that  would 
have been difficult to detect using previously described as- 
says.  The main feature of this  assay involves the use of 
[3H]galactose  to  biosynthetically  "tag"  glycoproteins  in 
the Golgi apparatus/TGN, thereby avoiding the labeling of 
unassembled Ii and class II 0tl3-dimers: In most APCs Ii is 
present  in  a  large  excess over class  II  a-  and  13-chains 
(Kvist et al.,  1982;  Roche et al.,  1992),  and these free Ii 
molecules are for the most part ER retained (Marks et al., 
1990).  Therefore, pulse-chase labeling studies using con- 
ventional  biosynthetic labels  such  as  [35S]methionine or 
[3H]leucine are confounded by the fact that at early times 
of chase  a  disproportionate  percentage  of radiolabel  is 
present on Ii, whereas at later times of chase newly synthe- 
sized  (nonradioactive) class  II a-  and  B-chains associate 
with  ER-retained  Ii,  become  transport  competent,  and 
leave the ER. The combination of these factors leads to 
nonsynchronous class II transport and makes analysis of 
transient populations of molecules difficult to detect. On 
the other hand, labeling assembled al3Ii complexes in the 
Golgi apparatusFFGN with [3H]galactose circumvents these 
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and p35 from a13 heterodimers is inhibited  by 
leupeptin.  B-LCL 721.45 were radiolabeled 
with [3H]galactose for 45 min in the absence 
or presence of leupeptin.  The cells were pel- 
leted by centrifugation  to remove free radio- 
label, and chased in regular medium contain- 
ing 0.02 mg/ml unlabeled D-galactose and 0.1 
mM o-mannose in the absence (-) or pres- 
ence (+) of 1 mM leupeptin. After incubation 
for 30, 60, 90, or 180 min  at 37°C, the cells 
were washed  in  ice  cold  RPMI,  iysed,  and 
MHC class II molecules  were isolated using 
mAb DA6.147.  After immunoprecipitation, 
samples were analyzed using two-dimensional 
PAGE. 
problems, as there is no pool of unassembled molecules to 
interfere with the pulse-chase study. 
Using this labeling system, we have demonstrated that 
MHC class II etl3Ii complexes can be detected at the sur- 
face of B-LCL within 10 min of chase from the Golgi ap- 
paratus/TGN. This rate of transport rivals that of class I 
MHC molecules, glycoproteins thought to arrive at the cell 
surface by the "default" pathway. However, unlike class I 
molecules, newly synthesized MHC class II molecules are 
rapidly internalized once they arrive at the cell surface by 
the recognition of an internalization signal in the cytosolic 
domain  of Ii (Roche  et  al.,  1993).  For  this  reason,  otl3Ii 
complexes exist only transiently on the cell surface and are 
therefore  present  there  at  low levels under  steady-state 
conditions.  Indeed, we have previously shown that ~3% 
of  all  surface  class  II molecules  are  associated  with  Ii 
(Roche et al., 1993).  However, due to their rapid uptake 
into the endocytic pathway, even this small population of 
molecules at the surface can represent a  significant frac- 
tion  of the  total  biosynthetic  pool  of newly  synthesized 
class II ~3Ii complexes that passes through the cell surface 
en route to antigen processing compartments. 
The newly synthesized al3Ii complexes detected in this 
study may have arrived at the cell surface directly from the 
TGN. Alternatively, the c~lMi complexes may have passed 
rapidly through  a  recycling endosome before subsequent 
transport to the cell surface, as shown for the transferrin 
receptor (Futter et al., 1995). However, recycling of inter- 
nalized class II alMi complexes is very inefficient: over a 
30-60-min period most of the  surface Ii is degraded  and 
dissociates from internalized class II molecules (Roche et 
al.,  1993  and  present  study).  Nevertheless,  we  have  re- 
cently measured that about half of the alMi complexes re- 
maining after 30 min of internalization reappear at the cell 
surface in 10 min (data not shown), indicating that limited 
recycling of surface al3Ii complexes does occur in B-LCL. 
Surprisingly, and in contrast to the results obtained with 
al3Ii complexes containing the p33 form of Ii, class II mol- 
ecules associated with the p35 form of Ii did not appear on 
the plasma membrane. This was demonstrated both by the 
absence of Ii-p35 in  immunoprecipitations from surface- 
iodinated  cells and by the  lack of NANAse trimming of 
[3H]galactose-labeled  Ii-p35  molecules.  These  a13Ii-p35 
complexes were not simply retained in or retrieved from 
the  Golgi apparatus since their dissociation from class II 
molecules was inhibited by the endosomal proteinase in- 
hibitor leupeptin. Unlike the results obtained on ice, incu- 
bation with NANAse at 37°C for 5  min did  reveal some 
sialic acid trimming, presumably as a consequence of inter- 
nalization of NANAse into early endosomes during the in- 
cubation. We conclude from these data that the transport 
route taken by class II ~Ii  complexes is regulated by the 
isoform of Ii: in the absence of a  p35 form in the  (c~13Ii)3 
complex, surface arrival is  possible  (either  directly from 
the TGN or via recycling endosomes), whereas the pres- 
ence of an Ii-p35 cytosolic tail prevents transport of the 
al3Ii complex to  the  cell  surface.  Since  Ii trimers in  the 
nonameric al3Ii complex can contain  a  mixture of Ii-p33 
and Ii-p35 (Marks et al.,  1990;  Roche et al.,  1991;  Lamb 
and  Cresswell,  1992),  these  results  also  suggest  that  the 
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Figure 8.  Ii-p35 containing ecl3Ii complexes do not travel via the 
cell surface,  but are targeted directly  to early/late  endosomes. 
B-LCL JY were radiolabeled  for 15 min with [3H]galactose and 
were chased  by adding 0.2 mg/ml unlabeled  D-galactose to the 
cells for 0, 15, 30, or 45 rain. After each chase point the cells were 
split three ways; one sample served as a negative control; a sec- 
ond sample was digested with NANAse for 2 h on ice (open sym- 
bols); a third sample was digested  with NANAse for 5 min at 
37°C (filled symbols). Ii-p35 containing ~tl3Ii complexes were iso- 
lated using an affinity-purified rabbit anti-p35 antibody. The im- 
munoprecipitates  were analyzed in the 13-galaetosidase assay and 
the relative percent terminal galactose was determined. 
targeting signal in the Ii-p35 tail dominates over the signal 
present in the Ii-p33 tail. 
The fraction of the biosynthetic pool of class II mole- 
cules that are transported to the cell surface before arrival 
in antigen processing compartments cannot be accurately 
quantitated for several reasons. The very short half-life of 
cell surface  a~Ii  complexes makes  it  difficult to  detect 
them quantitatively, since at any time during a pulse-chase 
experiment most of the labeled molecules will  be either 
still inside the cells or already internalized. Furthermore, 
true chase conditions cannot be achieved with galactose; 
as a result, labeled molecules that have not yet reached the 
surface continue to be produced during short chase times. 
Finally, the extent of recycling of internalized e~Ii com- 
plexes will affect the estimate of how many newly synthe- 
sized  molecules  reach  the  cell  surface.  Nevertheless,  a 
highly reproducible 5% of the biosynthetic pool of class II 
e~13Ii complexes was detected at the cell surface shortly af- 
ter  egress  from  the  Golgi  apparatus/TGN.  Considering 
that this value was determined by treating cells with NANAse 
on ice, a much greater fraction of the new class II mole- 
cules  must  pass  through  the  cell surface.  Indeed, treat- 
ments  with  NANAse  at  37°C  for  5  min  revealed  that 
N15%  of the total pool of radiolabeled ot[3Ii complexes 
was  accessible to NANAse  digestion. This short incuba- 
tion time was chosen to exclude the possibility of trimming 
class II molecules that are transported through late endo- 
somes. Previous studies have shown that at least 30 min is 
required  for fluid-phase  markers  to  reach  prelysosomal 
antigen  processing  compartments  such  as  the  originally 
defined MIIC (Peters et al., 1991, 1995). Therefore, a sub- 
stantial fraction of the biosynthetic pool of class II mole- 
cules passes  through  the  plasma  membrane/early endo- 
some compartment before their delivery to antigen processing 
compartments. 
Active transport through the cell surface was  also  re- 
vealed in a study using chimeric proteins composed of the 
cytosolic tail and transmembrane domains of Ii and the ex- 
tracellular domain of the transferrin receptor (Odorizzi et 
al., 1994). This chimeric protein led to uptake of transfer- 
rin  that was  even more efficient than that  mediated by 
wild-type transferrin receptor. From the measurements of 
steady-state surface levels, the percentage of internalized 
molecules at steady state,  the rate of synthesis of these 
molecules, and their rate of degradation, the authors cal- 
culated that ~20% of these chimeric molecules trafficked 
via the cell surface (Odorizzi et al., 1994).  However, this 
estimate is based on the accurate determination of these 
four independent variables, so that even a twofold error in 
any given variable will dramatically alter the estimate of 
trafficking via the cell surface. Nevertheless, it is impor- 
tant to reiterate that ~150,000 et[3Ii complexes are inter- 
nalized in a B-LCL every hour (Roche et al., 1993)  and 
that all of the [3H]galactose-labeled ctBIi complexes syn- 
thesized in the experiments described here lose Ii and give 
rise to mature class II eta3 dimers. Therefore, irrespective 
of whether these internalized complexes represent a  mi- 
nority or a majority of the biosynthetic pool (a distinction 
that cannot be made accurately with existing techniques), 
they represent a very large number of molecules as com- 
pared to the ~300 surface class II-peptide complexes re- 
quired to stimulate T cells (Harding and Unanue, 1990). 
The demonstration that a substantial fraction of newly 
synthesized class II et[Mi complexes is transported to the 
plasma membrane/early endosomes before delivery to an- 
tigen processing compartments such as the MIIC is in ex- 
cellent agreement with several recent studies. Germain's 
laboratory has shown that Ii is targeted predominantly to 
early endosome-like structures in the absence of class II 
molecules (Romagnoli et al., 1993) and that peptide load- 
ing onto newly synthesized class II molecules can occur in 
multiple  endocytic compartments  (Castellino  and  Ger- 
main,  1995). Pieters et al.  (1991) have localized class  II 
molecules and Ii in early endosomes, multivesicular bod- 
ies,  and  late endosomes/prelysosomes  in  human  mela- 
noma cells. Marie et al. (1994) found intact Ii in conven- 
tional endosomes before the generation of Ii fragments in 
more lysosome-like compartments in B-LCL. Finally, Ami- 
gorena et al. (1995) found the pl0 fragment of Ii (but not 
intact  Ii)  in  the  murine  B  cell antigen  processing com- 
partment  "CIIV," suggesting that most class II o~13Ii-pl0 
complexes reach this compartment only after arriving in 
endosomes as otl3Ii complexes. On the other hand, the pre- 
dominant localization of class II et~Ii in MIIC at steady 
state is also compatible with the results presented here. 
Steady-state measurements cannot determine pathways of 
transport, although they were invaluable for the identifica- 
tion  of  processing  compartments  in  antigen-presenting 
cells. By analogy, the mannose-6-phosphate receptor has 
been localized to late endosomes by immunoelectron mi- 
croscopy (Klumperman et al., 1993), and until recently, it 
was thought to arrive in this compartment directly from 
the TGN. However, kinetic studies demonstrated that this 
receptor was in fact targeted to early endosomes before 
delivery in late endosomes (Ludwig et al., 1991). Taken to- 
gether, this suggests that the accumulation of class II mole- 
cules  in  MIIC  represents  the  fact that  egress  from this 
compartment is the rate-limiting step in class II molecule 
transport along the biosynthetic pathway. 
The strength of the endosomal targeting signal in the Ii 
Warmerdam et al. Transport of  MHC Class H Molecules to Endosomes  289 cytoplasmic tail is dependent on Ii trimerization (Arneson 
and Miller, 1995). The choice between the intracellular or 
the surface route may also be controlled by the strength of 
the  cytoplasmic  tail  signal.  The  cytoplasmic  tail  of  the 
CD3~/  chain  carries two  targeting  signals,  one  tyrosine- 
based, and another made up of a di-leucine motif (Letour- 
neur  and  Klausner,  1992).  Either  signal  alone  leads  to 
transport to the cell surface and retrieval by internaliza- 
tion, whereas the presence of both signals results in trans- 
port to lysosomes  without detectable  surface  expses~on 
(Letourneur and Klausner, 1992). The cytoplasmic tail of 
Ii is devoid of tyrosine but contains a di-leucineqike motif 
that  is  essential  for internalization  (Pieters  et  al.,  1993; 
Bremnes et al., 1994; Odorizzi et al., 1994). Tlae very basic 
16--amino  acid extension on the p35 cytoplasmic tail may 
streagtlma  the  signal(s)  present  on  the ~33  cytoplasmic 
tail. Studies  on  this  basic  amino  acid extension  will be 
complicated by the fact that it ¢a~/es a strong ER-reten- 
tion motif (Scha_,ize Or af., 1994) that can be overcome by 
assembly of Ii with class II molecules. The identification of 
adaptor or receptor molecules that interact with the p33 
and the p35 forms of the Ii cytoplasmic tail will clarify the 
role of the p35 isoform and the mechanism by which it pre- 
vents surface arrival of class II ctl3Ii complexes. Finally, the 
novel  assay  described  here  should  prove  very  useful  to 
study the transport of class II molecules in different cell 
types and the transport of other endosomal/lysosomal pro- 
teins in general. 
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